GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: ChAglyCD3 | TRX4
Compound class:
Antibody
Comment: Otelixizumab is a chimeric humanized IgG1 monoclonal antibody targeting the CD3E component of the T cell receptor. The antibody is aglycosylated. Otelixizumab was investigated as a potential treatment for autoimmune diseases including type I diabetes [3-4].
Peptide sequences for this antibody are available from its IMGT/mAb-DB record. |
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 8864 | otelixizumab |
Synonyms ![]() |
| ChAglyCD3 | TRX4 |
Database Links ![]() |
|
| Specialist databases | |
| IMGT/mAb-DB | 235 |
| Other databases | |
| GtoPdb PubChem SID | 252166668 |
| Search PubMed clinical trials | otelixizumab |
| Search PubMed titles | otelixizumab |
| Search PubMed titles/abstracts | otelixizumab |
| Wikipedia | Otelixizumab |